Literature DB >> 12970171

Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis.

Peter J Hurlin1, Zi-Qiang Zhou, Kazuhito Toyo-oka, Sara Ota, William L Walker, Shinji Hirotsune, Anthony Wynshaw-Boris.   

Abstract

Mnt is a Max-interacting transcriptional repressor that has been hypothesized to function as a Myc antagonist. To investigate Mnt function we deleted the Mnt gene in mice. Since mice lacking Mnt were born severely runted and typically died within several days of birth, mouse embryo fibroblasts (MEFs) derived from these mice and conditional Mnt knockout mice were used in this study. In the absence of Mnt, MEFs prematurely entered the S phase of the cell cycle and proliferated more rapidly than Mnt(+/+) MEFs. Defective cell cycle control in the absence of Mnt is linked to upregulation of Cdk4 and cyclin E and the Cdk4 gene appears to be a direct target of Mnt-Myc antagonism. Like MEFs that overexpress Myc, Mnt(-/-) MEFs were prone to apoptosis, efficiently escaped senescence and could be transformed with oncogenic Ras alone. Consistent with Mnt functioning as a tumor suppressor, conditional inactivation of Mnt in breast epithelium led to adenocarinomas. These results demonstrate a unique negative regulatory role for Mnt in governing key Myc functions associated with cell proliferation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970171      PMCID: PMC212711          DOI: 10.1093/emboj/cdg442

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

Review 1.  The interplay between Mad and Myc in proliferation and differentiation.

Authors:  Z Q Zhou; P J Hurlin
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

Review 2.  Deconstructing myc.

Authors:  R N Eisenman
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

3.  Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation.

Authors:  S R Eberhardy; C A D'Cunha; P J Farnham
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

Review 4.  Transgenic mouse models of human breast cancer.

Authors:  J N Hutchinson; W J Muller
Journal:  Oncogene       Date:  2000-12-11       Impact factor: 9.867

5.  Analysis of C-MYC function in normal cells via conditional gene-targeted mutation.

Authors:  I M de Alboran; R C O'Hagan; F Gärtner; B Malynn; L Davidson; R Rickert; K Rajewsky; R A DePinho; F W Alt
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

6.  c-Myc regulates mammalian body size by controlling cell number but not cell size.

Authors:  A Trumpp; Y Refaeli; T Oskarsson; S Gasser; M Murphy; G R Martin; J M Bishop
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

7.  Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes.

Authors:  Antje Menssen; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

8.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

Review 9.  The INK4a/ARF network in tumour suppression.

Authors:  C J Sherr
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

10.  Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.

Authors:  G J TODARO; H GREEN
Journal:  J Cell Biol       Date:  1963-05       Impact factor: 10.539

View more
  28 in total

1.  Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.

Authors:  Shala Dezfouli; Antony Bakke; Jie Huang; Anthony Wynshaw-Boris; Peter J Hurlin
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

Review 2.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 3.  Control of vertebrate development by MYC.

Authors:  Peter J Hurlin
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 4.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

5.  MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer.

Authors:  Arnaud Augert; Haritha Mathsyaraja; Ali H Ibrahim; Brian Freie; Michael J Geuenich; Pei-Feng Cheng; Sydney P Alibeckoff; Nan Wu; Joseph B Hiatt; Ryan Basom; Adi Gazdar; Lucas B Sullivan; Robert N Eisenman; David MacPherson
Journal:  Cancer Cell       Date:  2020-05-28       Impact factor: 31.743

Review 6.  Target gene-independent functions of MYC oncoproteins.

Authors:  Apoorva Baluapuri; Elmar Wolf; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2020-02-18       Impact factor: 94.444

7.  MYC needs MNT.

Authors:  Jason M Link; Peter J Hurlin
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

8.  A repressor protein, Mnt, is a novel negative regulator of vascular smooth muscle cell hypertrophy by angiotensin II and neointimal hyperplasia by arterial injury.

Authors:  Takehiko Takayanagi; Akito Eguchi; Akira Takaguri; Akinari Hinoki; Allison M Bourne; Katherine J Elliott; Peter J Hurlin; Satoru Eguchi
Journal:  Atherosclerosis       Date:  2013-03-13       Impact factor: 5.162

9.  A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis.

Authors:  Jason M Link; Sara Ota; Zi-Qiang Zhou; Colin J Daniel; Rosalie C Sears; Peter J Hurlin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

10.  The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects.

Authors:  Sara Ota; Zi-Qiang Zhou; Jason M Link; Peter J Hurlin
Journal:  Hum Mol Genet       Date:  2009-04-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.